The Longevity Centers Introduces Stellate Ganglion Block (SGB) Injections for Nervous System Regulation

February 20, 2025 10:00 AM

Patients at The Longevity Center have another safe and effective option for reducing symptoms related to stress, anxiety, pain, and inflammation. Stellate Ganglion Block (SGB) injections, which are now available at The Longevity Center's integrative health clinic in West Palm Beach, Florida, are an innovative tool for helping address imbalances in the autonomic nervous system. By adding the injections to its treatment list, The Longevity Center...

Read more

Grant Porteous Joins ACU-Serve as New Chief Technology Officer

February 20, 2025 10:00 AM

ACU-Serve, a leading provider of healthcare revenue cycle optimization solutions, has announced the appointment of Grant Porteous as its new Chief Technology Officer (CTO). With a proven track record in technology leadership and product development, Porteous will play a critical role in advancing ACU-Serve's technology infrastructure and scaling its innovative solutions.Grant brings more than 25 years of experience in healthcare technology, most...

Read more

Global Over-The-Counter (OTC) Veterinary Drugs Market Poised for Strong Growth, Projected to Reach USD 22,359.0 Million by 2035

February 20, 2025 9:15 AM

The global market for Over-The-Counter (OTC) veterinary drugs is poised for significant growth in the coming years. With an estimated market value of USD 10,259.2 million in 2025, the sector is on track to reach an impressive USD 22,359.0 million by 2035. This growth represents a robust compound annual growth rate (CAGR) of 8.4% over the forecast period from 2025 to 2035.In 2024, the OTC veterinary drug market generated USD 9,528.8 million,...

Read more

Groundbreaking Clinical Study Shows Evidence That Xironetic's IntraOpVSP Augmented Reality System Reduces Blood Loss in Craniofacial Surgery

February 20, 2025 9:00 AM

Xironetic announced today the publication of data from a recent study evaluating the potential benefits of augmented reality guidance with Xironetic's IntraOpVSP system in patients undergoing craniofacial surgery. The results of this study - one of the first of its kind in the field of craniomaxillofacial surgery - were published in the leading peer-reviewed academic journal FACE founded by the American Society of Maxillofacial Surgeons (ASMS)...

Read more

CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum

February 20, 2025 9:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the 18th Annual European Life Sciences CEO Forum on Wednesday, February 26, 2025 at 3:20 PM CET / 9:20 AM EST in Zurich,...

Read more

ZetrOZ Systems' Dr. Rajiv Mallipudi to Present Webinar on Sustained Acoustic Medicine for Workplace Injuries

February 20, 2025 9:00 AM

ZetrOZ Systems, makers of the sam® wearable ultrasound unit, announces a webinar on the use of sustained acoustic medicine in occupational and environmental medicine.Dr. Rajiv Mallipudi, assistant clinical professor at the Yale School of Medicine and director of medical education at ZetrOZ Systems, will conduct the webinar, scheduled for noon to 1:00 PM on Friday, February 28, 2025. The webinar is presented in partnership with the New England...

Read more

Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Ultherapy for Non-Invasive Skin Lifting and Tightening

February 20, 2025 9:00 AM

Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are proud to announce the introduction of Ultherapy, an FDA-cleared non-invasive procedure for lifting and tightening the skin on the face, neck, and chest. As the demand for non-surgical cosmetic treatments continues to grow, Dr. Bajoghli and his team remain committed to offering the most advanced and effective solutions for their patients' aesthetic needs.Ultherapy uses focused...

Read more

Eviva Partners Launches #Mahakills Campaign to Raise Awareness of the New US Administration's Revolt Against Science, Medicine and the Media

February 20, 2025 8:20 AM

Eviva Partners today announced the launch of #MAHAKILLS, a public education initiative focused on raising awareness of the impact the Administration's "Make America Healthy Again" program is poised to have in health outcomes in the US.The #MAHAKILLS campaign aims to highlight several key areas affecting healthcare delivery and medical science in America, including:Reduced healthcare agency staffing and budgetsWorsening mistrust in medical...

Read more

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

February 20, 2025 7:30 AM

Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). Proceeds from the transaction totaled approximately $3.8...

Read more

3D Bioprinted Human Tissue Market Growth USD 3,526.2 Million by 2035 with a 4.0% of CAGR, Driven by Transplant Demand, Drug Testing, and Personalized Medicine

February 20, 2025 6:30 AM

The global 3D bioprinted human tissue market is poised for significant growth over the next decade. Valued at USD 2,373.0 million in 2025, the market is projected to reach USD 3,526.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.0% during this period. This expansion is driven by advancements in bioprinting technology, increased investment in regenerative medicine, and the rising demand for personalized healthcare...

Read more

Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application

February 20, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that its exclusive, out-licensed patent application for "Variants of SIRT6 for Use in Preventing and/or Treating Age-Related Diseases" has successfully progressed through the Supplementary European...

Read more

IRLAB Receives Positive Feedback from EMA Confirming Alignment with FDA on Phase III Program for Mesdopetam

February 20, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 February, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB a company discovering and developing novel treatments for Parkinson's disease, today announces that the European Medicines Agency (EMA) has provided positive feedback on the company's proposed design for the Phase III program of mesdopetam. Based on EMA's guidance, IRLAB can now proceed with preparations for the...

Read more

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

February 19, 2025 4:05 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth quarter and full-year 2024 financial results and other key updates for the quarter."2024 was a year of delivering on our commitments, where we achieved the high-end of our revenue guidance range, and exceeded our adjusted EBITDA excluding Bausch + Lomb, and adjusted operating cash flow guidance expectations. We generated...

Read more

Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes

February 19, 2025 1:10 PM

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT)...

Read more

Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq

February 19, 2025 1:10 PM

Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition...

Read more

CNY Fertility Supports Executive Order to Expand IVF Access and Reduce Costs

February 19, 2025 1:00 PM

Dr. Robert Kiltz, Founder and CEO of CNY Fertility, welcomes President Donald J. Trump's recent Executive Order aimed at expanding access to in vitro fertilization (IVF) and reducing out-of-pocket costs for fertility treatment. As a national leader in affordable IVF, CNY Fertility has long been committed to making parenthood possible for individuals and families, regardless of financial barriers."Access to fertility care should not be a...

Read more

Sober Safe Spot Returns to Mardi Gras for the Fourth Year

February 19, 2025 1:00 PM

With the arrival of 2025's Carnival season, Avenues Recovery Center is once again erecting Sober Safe Spots along the Uptown New Orleans parade route to benefit the extended recovery community.The mission of Sober Safe Spot is to strengthen and support the recovery community by creating safe, substance-free spaces at every major recreational event.For the past three years, Sober Safe Spot has served as a haven for those in recovery who wish to...

Read more

My Quest Story - Esmeralda Bonilla

February 19, 2025 12:20 PM

My mom worked for Quest Diagnostics, and she always talked about what a great company it is, so I had long waited for an opportunity to also work for Quest. I actually saw three job openings for the Logistics team, and I applied for all of them to get the opportunity to work for this company. When I filled out the application, I felt the positive vibes because I knew this was my chance. Since joining Quest, I have learned to problem solve much...

Read more

The Centrifuge Sessions: How Gilead Sciences Is Impacting Autoimmune Disease

February 19, 2025 11:05 AM

Take a spin through the latest in Gilead's science and innovation in our new series, The Centrifuge Sessions. Today we sit down with D. Barry Crittenden, Executive Director of Clinical Development, to discuss how Gilead is helping make an impact for people living with primary biliary cholangitis (PBC), a rare autoimmune disease that affects the liver.Gilead SciencesGilead Sciences, Inc. is a research-based biopharmaceutical company that...

Read more

Miracles for Mya Hosts Second Annual Gala in March to Support Children Battling Cancer

February 19, 2025 9:10 AM

Miracles for Mya, a beacon of hope for families facing pediatric cancer, is thrilled to announce its Second Annual Miracles for Mya Gala on March 8, 2025. The event will celebrate the organization's remarkable impact, including providing over $56,000 in holiday gifts to children battling cancer in 2024. It will also raise crucial funds to continue its mission of delivering joy and support to children with cancer and their families."Building on...

Read more